Related Experiment Video
Updated: Aug 9, 2026
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Treatment of metastatic prostate cancer. Lessons from the androgen receptor
1Division of Hematology/Oncology, Beth Israel Hospital, Boston, Massachusetts, USA.
Abstract:
The exquisite hormonal dependence of prostate cancer continues to provide an opportunity and a challenge for oncologists. It is clear that future efforts in the laboratory should include determining the frequency and spectrum of AR mutations in AI prostate cancer, the development of more effective antiandrogens, and understanding in greater detail how the AR stimulates the growth of prostate cancers. These efforts may eventually lead to treatments that greatly reduce any stimulatory effects of the AR on prostate cells, possibly resulting in a significant improvement in disease-free survival and, perhaps in conjunction with other modalities, cure of some earlier stages of disease. And even for patients with advanced disease, because hormonal therapy is generally fairly well tolerated even in the typically older prostate cancer patient, defining the contribution of AR-mediated growth to AI disease will be critically important.
Insights
Future research on prostate cancer will focus on androgen receptor (AR) mutations and developing better antiandrogens. Understanding AR
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Prostate cancer growth is highly dependent on hormonal signaling, particularly the androgen receptor (AR).
- Current treatments aim to disrupt this hormonal dependence, but challenges remain in managing advanced disease.
Purpose of the Study:
- To outline critical future research directions for understanding and targeting AR in prostate cancer.
- To identify key areas for developing more effective antiandrogen therapies.
- To elucidate the mechanisms by which AR stimulates prostate cancer growth.
Main Methods:
- This abstract outlines proposed research directions, not specific experimental methods.
- Focuses on laboratory-based investigations into AR mutations and signaling pathways.
- Emphasizes the need for improved antiandrogen drug development.
Main Results:
- The abstract does not present experimental results but proposes future research outcomes.
- Anticipates that understanding AR's role will lead to improved treatments.
- Suggests potential for enhanced disease-free survival and cure in earlier stages.
Conclusions:
- Continued research into AR biology is crucial for advancing prostate cancer treatment.
- Developing novel antiandrogens and understanding AR-mediated growth are key priorities.
- Targeting AR offers a promising strategy for improving outcomes in both early and advanced prostate cancer.
More Related Videos
Related Concept Videos
02:38Mitogens and the Cell Cycle
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
02:56Treatment Resistent Cancers